Abstracts and poster presentations |
Year |
Month |
| Jeffrey D. Bjorge, KeYun Chen, Melanie Funnell, Anthony Magliocco and Donald J. Fujita. Inhibition of breast cancer cell anchorage-independent growth and tumor metastasis in mice through siRNA-targeted inactivation of Src signaling pathways. Oncogene Meeting, Frederick, MD, USA. June 16-20, 2004. |
2004 |
Jun |
| Temple WJ, Arthur K, de Haas W, Lindsay R, Magi E, Ketcham A. The challenge of reconstruction in achieving local control after resection of groin sarcoma. Presented at 51st Annual Meeting Society of Pelvic Surgeons, Oslo/Bergen, Norway. 22-28 07 2001 |
2001 |
Jul |
| Baliski CR, Temple WJ, Arthur K, Schachar NS. Fibromatosis: A novel approach for local control. Presented by CR Baliski at Canadian Society of Surgical Oncology Scientific Meeting, Montreal, PQ. 21 04 2001 |
2001 |
Apr |
| Smith, C.J. Non-Small Cell Lung Cancer/Chemo/Tumour Group Guidelines sponsored by Bristol-Myers Squibb Pharmaceutical Group March 29, 2001 |
2001 |
Mar |
| Craighead P, Pearcey R, Stuart G. Pelvic Control using tirapzamine, Cisplatin and Radiotherapy in locally advanced cervix cancer patients. Int. Society of Radiation Oncology Proceedings (Radiotherapy and Oncology)319: page S87. 2001 (poster). |
2001 |
|
| Smith, C.J. Palliative Care 2000: Out of the Past and Into the Future/Enhancing Communication – 12th Annual Palliative Care Conference Education and Research Days, Edmonton, Alberta. October 23 & 24, 2000. |
2000 |
Oct |
| Mew, D. Dissemination of Tumor Cells in Electrocautery Plume Abstract for SAGES (Society of American Gastrointestinal Endoscopic Surgeons accepted Dec. 1999 for SAGES Scientific Session March 29-April 1, 2000, Atlanta, GA USA |
2000 |
Mar |
| M.A. Chaudhry, P. Duggan, C.B. Brown, D. Stewart, F.D. Ruether, S. Glück, D. Morris, F.A. Russell, Alberta BMT Program, Calgary, Alberta, Canada: Myeloablative chemotherapy for allogeneic transplantation with a fludarabine/busulfan protocol (Flubup): Comparison with Bucy. Abstracts from the Tandem BMT Annual Meeting. Biology of Blood and Marrow Transplantation 2000, 6:140, #24. |
2000 |
|
| P.R. Duggan, A. Chaudhry, D. Guo, F. Luider, I. Auer, F. Klassen, D. Morris, S. Glück, F. Russell, D. Stewart: Total CD34+ dose/kg predicts long-term outcome following autologous blood stem cell transplant (ASCT). Abstracts from the Tandem BMT Annual Meeting. Biology of Blood and Marrow Transplantation 2000, 6:142, #37. |
2000 |
|
| D.A. Stewart, D. Guo, S. Glück, D. Morris, A. Chaudhry, F. Klassen, F. Luider, I. Auer, C. Brown, F.A. Russell: Low CD34+ cell dose is advsersely associated with relapse-free (RFS) and overall survival )OAS) following autologous blood stem cell transplantation (ASCT). Abstracts from the Tandem BMT Annual Meeting. Biology of Blood and Marrow Transplantation 2000, 6:129, #50. |
2000 |
|
| F.A. Russell, A. Chaudhry, P. Duggan, D. Stewart, F.D. Ruether, S. Glück, D. Morris, C.B. Brown, Alberta BMT Program, Calgary, Alberta, Canada: Preliminary experience with once daily intravenous Busulfan (BU): A comparison with conventional oral BU in combination with Fludarabine as conditioning for allogeneic BMT. Abstracts from the Tandem BMT Annual Meeting. Biology of Blood and Marrow Transplantation 2000, 6:156, #88 |
2000 |
|
| R.M. Syme, D.H. Callaghan, S. Bitner, D. Stewart, S. Glück: Generation of dendritic cells in vitro from patients with breast cancer, and lymphoma and normal donors: Differences in steady state versus mobilized blood. Abstracts from the Tandem BMT Annual Meeting. Biology of Blood and Marrow Transplantation 2000, 6:160, #101. |
2000 |
|
| F.A. Russell, P. Duggan, A.M. Chaudhry, D. Stewart, S. Glück, D. Ruether, D. Morris, K. Booth, M. Coopes, R. Anderson, J. Wolff, M. Egeler, C.B. Brown. Unrelated donor BMT recipients given pretransplant antithymocyte globulin have outcomes equivalent to matched sibline BMT: a matched pair analysis. Abstracts of the American Society of Hematology 2000, #1788, 416a. |
2000 |
|
| R.M. Syme, P. Duggan, T. Bryan, D. Stewart, S. Glück. Cultured dendritic cells can prime potent cytotoxic T lymphocyte responses to chronic myelogenous leukemia. Abstracts of the American Society of Hematology 2000, #3862, 46b. |
2000 |
|
| D.A. Stewart, D. Guo, J. Luider, I. Auer, J. Klassen, D. Morris, K.A. Valentine, C.B. Brown, A. Chaudhry, S. Glück, F.A. Russell. CD3-16+56+ NK cell count independently predicts autologous blood stem cell mobilization (BSCM). Abstracts of the American Society of Hematology 2000, #5127, 319b |
2000 |
|
| F.A. Russell, A.M. Chaudhry, P. Duggan, D. Stewart, D. Ruether, D. Morris, S. Glück, C.B. Brown. Daily intravenous busulfan (BU): comparison with conventional oral BU in combination with fludarabine as conditioning for allogeneic stem cell transplant. Abstracts of the American Society of Hematology 2000, #5188, 333b. |
2000 |
|
| F.A. Russell, A.M. Chaudhry, P. Duggan, D. Stewart, D. Ruether, S. Glück, D. Morris, M.J. Coppes, R. Anderson, J. Wolff, M. Egeler, K. Booth, S. Desai, L. Larratt, R. Turner, C.B. Brown. Haploidentical transplants using partial T-cell depletion, cyclosporin and Low-dose antithymocyte globulin as GVHD prophylasix. Abstracts of the American Society of Hematology 2000, #5326, 364b. |
2000 |
|
| S. Glück, M. Crump, D. Stewart, A. Arnold, S. Couban, P. Kirkbride, M. Levine, S. O’Reilly, K. Pritchard, A. Smith, D. Tu, J. Dansey, S. Marlin and L. Shepherd for the National Cancer Institute of Canada clinical Trials Group (NCI-C CTG), Canada. A randomized comparative trial of high dose chemotherapy and autologous stem cell support versus standard dose chemotherapy following response to anthracycline or taxane based chemotherapy in women with metastatic breast cancer: NCI-C CTG MA.16. Abstracts of the Bone Marrow Transplantation, EBMT International Conference on High-Dose Chemotherapy in Breast and Ovarian Cancer 2000, #14, S10. |
2000 |
|
| S. Glück, R. Syme, D. Stewart: CerbB-2/HER-2 overexpression in breast cancer-prognostic significance and target for therapy. Abstracts from the 13th International Symposium on Molecular Biology of Hematopoiesis 2000, (in press). |
2000 |
|
| R.M. Syme, D. Callaghan, D. Stewart ,S. Glück: In vitro generation of dendritic cells from normal donors and patients with breast cancer, or lymphoma: Differences in steady state versus mobilized blood. Abstracts from the 13th International Symposium on Molecular Biology of Hematopoiesis 2000, (in press). |
2000 |
|
| Giacomantonio CA, Temple WJ. Local recurrence in breast cancer – An issue of quality of surgery. Presented at 49th Annual Meeting Society of Pelvic Surgeons, Banff, AB. 12-15 09 1999 |
1999 |
Sep |
CM Friedenreich, HE Bryant, F Alexander, J Hugh, L Marx, J Danyluk, DL Page - Epidemiologic, Histologic and Radiologic Predictors of Benign Breast Biopsies: A Nested Case-Control Study in the Alberta Breast Screening Program. Canadian Society for Epidemiology & Biostatistics, Meeting, Vancouver, B.C. May 1999
|
1999 |
May |
CM Freidenreich, HE Bryant, CM Freidenreich, F Alexander, J Hugh, L Marx, J Danyluk, DL Page - Risk Factors for Benign Proliferative Breast Disease -
Canadian Society for Epidemiology & Biostatistics Meeting, Vancouver BC May 1999 |
1999 |
May |
CM Freidenreich, HE Bryant, F Alexander, J Hugh, L Marx, J Danyluk, DL Page - Epidemiologic, histologic and radiologic predictors for benign breast biopsies: a nested case-control study in the Alberta Breast
Screening ProgramUniversity of Calgary/Tom Baker Cancer Centre Oncology Research Day, April 1999, Calgary, Alberta
|
1999 |
Apr |
| Giacomantonio CA, Temple WJ. Local recurrence in breast cancer – An issue of quality of surgery. Presented by CA Giacomantonio at Canadian Society of Surgical Oncology Scientific Meeting, Toronto, ON. 24 04 1999 |
1999 |
Apr |
| Temple WJ, EB Saettler. Surgical needle localization breast biopsy – A technique to be reckoned with. Presented at 48th Annual Meeting of Society of Pelvic Surgeons, Sarasota, FL. 11-15 11 1998 |
1998 |
Nov |
| Giacomantonio CA, Temple WJ, McKinnon JG, Mew D. Persistent limb edema following sentinel lymph node dissection. Presented by CA Giacomantonio at Alberta Cancer Board Annual Scientific Meeting, Calgary, AB. 10 11 1998 |
1998 |
Nov |
| Craighead PS for the Breast site Committee. Survival after isolated chest wall or ipsilateral breast recurrence in operable breast cancer: analysis of the MA4 and MA5 adjuvant breast trials of the clinical trials group of the National Cancer Institute of Canada. Royal College, Toronto September 1998 (poster). |
1998 |
Sep |
| Sait K, Craighead PS, Stuart G, Nation J, Arthur K, Duggan M, Guo D. Retrospective review of patients treated at the Tom Baker Cancer Centre between 1984 and 1993 with Uterine Papilary Serous, Clear Cell or Mixed Endometrial Cancers. SGO conference, Victoria BC, June 1998. |
1998 |
Jun |
| Kane G, Young C, Doswell J, Blondeau L, Craighead PS, Kim et al. Development of a document representing competency skills for the Radiation Oncology Specialty. Conference on continuing Medical Education, Ottawa, March 1998. |
1998 |
Mar |
| Giacomantonio CA, Temple WJ. Is therapeutic radiation following breast conservation surgery always necessary? Presented by CA Giacomantonio at 1st World Congress of Surgical Oncology (SSO & WFSOS), San Diego, CA. 29 03 1998 |
1998 |
Mar |
|
